Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hepatitis C vaccine - Innogenetics

Drug Profile

Hepatitis C vaccine - Innogenetics

Alternative Names: E1 vaccine - Innogenetics; HCV E1 vaccine - Innogenetics; INNO 101; InnoVac-C; INNOVAX-C

Latest Information Update: 11 Sep 2007

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Innogenetics
  • Class Hepatitis C vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 07 Sep 2007 Discontinued - Phase-II for Hepatitis C in Belgium (IM)
  • 07 Sep 2007 Discontinued - Phase-II for Hepatitis C in Europe (IM)
  • 12 Jul 2005 Data presented at the 40th Annual Meeting of the European Association for the Study of the Liver (EASL-2005) have been added to the adverse events and Viral infections immunogenicity and therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top